Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

cGAS bends unpaired DNA to form an unconventional structure that hyperactivates the innate immune response.

bioRxiv : the preprint server for biology·2026

Same author

Beyond malaria prevention: sulfadoxine-pyrimethamine treatment in pregnancy selectively remodels the maternal gut microbiome to increase gestational weight gain and improve birthweight.

medRxiv : the preprint server for health sciences·2026

Same author

<i>Treponema pallidum</i> subsp. <i>pallidum</i> genetic population structure and relevance to syphilis prevention and treatment.

medRxiv : the preprint server for health sciences·2026

Same author

Efficacy of the serogroup B <i>Neisseria meningitidis</i> vaccine (4CMenB) in preventing experimental <i>Neisseria gonorrhoeae</i> urethral infection: a double-blind randomised controlled human challenge study protocol.

BMJ open·2026

Same author

Estimating the Sensitivity of Nontreponemal and Treponemal Antibody Tests in Primary Syphilis.

Sexually transmitted diseases·2026

Same author

Perspective on the pathogenic Neisseria: milestones, challenges, and future directions.

NPJ vaccines·2026

Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026

Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026

Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026

Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026

Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026

Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 9, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Promising developments in gonococcal vaccines.

Andreea Waltmann^1,2, Jane S Chen^2,3, Joseph A Duncan^1,2,4,5

¹Division of Infectious Diseases, Department of Medicine, School of Medicine.

Current Opinion in Infectious Diseases

|December 5, 2023

Summary

This summary is machine-generated.

New meningococcal vaccines show promise for preventing gonorrhea infections. Observational studies link these vaccines to reduced gonorrhea rates, potentially revitalizing gonococcal vaccine development.

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Jul 9, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Area of Science:

Vaccinology
Infectious Diseases
Microbiology

Background:

Development of a Neisseria gonorrhoeae vaccine has been challenging.
Neisseria meningitidis vaccines have historically been more successful.
Recent advances offer new hope for gonococcal vaccine development.

Conclusions:

Recent meningococcal vaccines, particularly those with OMV, have unexpectedly advanced gonococcal vaccine research.
Ongoing clinical trials are crucial for confirming the efficacy of these vaccines against gonorrhea.
These findings represent a significant breakthrough after decades of limited progress in gonococcal vaccine development.